Physician profile
Ronald V Gregush
NPI 1275625584
$2,631.72
in general payments reported to CMS, 2019-2025
11 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,273 · 2020: $238 · 2021: $151 · 2022: $165 · 2023: $512 · 2024: $131 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $261.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,277.22 | 2019-2025 | N/A |
| Djo, LLC | $784.08 | 2019-2024 | Procare |
| Linvatec Corporation | $248.86 | 2023 | Biobrace 23mm |
| Orthalign INC | $90.00 | 2019 | |
| Stryker Corporation | $82.86 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $42.08 | 2019 | |
| Depuy Synthes Sales INC. | $27.01 | 2019 | |
| Orthofix Medical, INC. | $25.77 | 2020-2021 | |
| Invictus Surgical Incorporated | $21.81 | 2025 | |
| Heron Therapeutics, INC. | $19.52 | 2022 | |
| Bioventus LLC | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Gregush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.